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Abstract 
Recent data confirmed the hypothesis suggested by historical studies that the ratio of peripheral 
blood monocytes to lymphocytes (M/L) is associated with the risk of tuberculosis (TB) disease. We 
retrospectively analyzed the electronic health records of tuberculosis and HIV-positive patients 
who had followed day-care programs at the AIDS Center of the University of Palermo, Italy.  
261 patients were recruited and divided into 6 groups as follows: healthy control group (HCG: 47 
pts), latent HIV negative infected TB group (LIG, 43 pts), active HIV negative tuberculosis (TAG: 
61 pts), treated tuberculosis HIV negative (TTG: 44 pts), HIV drug-naive patients tested TST and 
QFT-IT-negative with negative chest x-Ray (HIVnG: 44 pts), and HIV-tuberculosis coinfection 
(HIVTB-G: 22 pts). For each group, absolute lymphocyte (L), monocyte (M) and M/L ratio by 
peripheral blood was calculated.   
The mean value of monocytes in the TAG group was significant, the highest (0.70±0.37 1x10
3/μl) 
in comparison to HGC (0.70>0.44, p-value <0.05), HIVnG (0.70>0.40, p-value <0.05) and 
HIVTB-G (0.70>0.45, p-value<0.05). Monocyte to lymphocyte blood RATIO showed a significant 
difference between groups (p-value <0.001). In particular, the mean score of M/L ratio was higher 
in the TAG group compared to the HGC (0.49>0.27, p-value<0.05), LIG (0.49>0.29, p-
value<0.05), TTG (0.49>0.32) and HIVTB-G groups (0.49>0.27, p-value<0.05). 
Our data confirm a significant difference in monocyte to lymphocyte blood ratio in tuberculosis 
disease. These data may be useful for monitoring and revising implementation plans for the 
different phases of tuberculosis disease (latent Mycobacterium tuberculosis (MTB) infection versus 
TB active disease). 
Regarding HIV samples, the small sample size is somewhat offset by the need, fully satisfied in our 
sample, to enlist specific patients such as co-infected HIV/TBC who voluntarily submit to clinical 
trials in our geographical area.
PhOL     Guadagnino, et al.      23 (pag 22-33) 
 
 
http://pharmacologyonline.silae.it 
ISSN: 1820-8620 
Keywords: tuberculosis, monocyte to lymphocyte blood RATIO, HIV infection, co-infected 
HIV/TBC 
PhOL     Guadagnino, et al.     24 (pag 22-33) 
 
 
http://pharmacologyonline.silae.it 
ISSN: 1824-8620 
Introduction 
The proportion of reported TB case 
notifications increased from 22% in 2008 to 63% 
in 2013 1,2. Over the last decade, the number of 
tuberculosis cases (TBCs) in foreign-born persons 
has more than doubled, and the percentage of total 
cases is approximately 50%. This is probably 
because of an ongoing influx of refugees from 
other countries, which can contribute to the 
diffusion in Italy of a non-autochthonous 
microorganism [3-5]. 
In the same period, the distribution of cases 
reported to the Ministry of Health by age class 
and "non-Italian citizens" shows that the highest 
number of cases occurs in the intermediate age 
classes, with a peak in the 25-34 group which, 
moreover, is the most represented among non-
Italian citizens present in our country. Resistance 
among different species of microorganism to 
antimicrobial drugs has developed into a public 
health concern [6-8, 35-40,43].  
Among these microorganisms, we find TB. 
Multidrug-resistant (MDR) TB has increased from 
2008 to 2013, with 77.4% of strains isolated 
from migrants from 41 countries 8-10,50.  
Finally, TB/HIV co-infection is a substantial 
problem in the EU/EEA. The occurrence of TB in 
HIV-positive cases and the low TB treatment 
success rate indicate that TB control efforts need 
to address the migrant population 11,12. 
Recent studies focus on the prognostic value of 
lymphocytes, monocytes and calculated ratios in 
cancer and infected patients 12-15. There is 
increasingly compelling evidence that natural 
killer (NK) cells play a crucial role in host defense 
against viral infection [44-46]. Monocyte to 
lymphocyte ratio might also identify children who 
are highly protected and those who are refractory 
to protection with some vaccination [41,42].  
In view of recently published data on flow 
cytometry and phenotyping analysis regarding 
patients enrolled in our geographical area 12, we 
started the investigation to analyze blood cell 
count of lymphocytes, monocytes and 
monocyte/lymphocyte ratio in Italian and migrant 
HIV-infected and uninfected patients.  
Materials and Methods  
The study participants were 261 Caucasian HIV 
negative and HIV-infected patients, consecutively 
enrolled between January 2016 and January 2017, 
who were being followed-up prospectively at the 
Department of Infectious Diseases, University 
Hospital of Palermo, Italy. Demographic and HIV 
disease characteristics were recorded and assessed 
as previously reported 16,17. 
Full Blood Counts  
Leucocyte differential counts were performed at 
the “P. Giaccone” University Hospital, Pathology 
Laboratory, University of Palermo, Italy, an 
accredited clinical laboratory, using standard 
procedures on a Sysmex automated haematology 
analyser.  
ML ratio was calculated as the quotient of 
absolute monocyte and lymphocyte counts. 
We have defined as affected by active 
tuberculosis all patients with  
Mycobacterium tuberculosis complex (MTBC) 
isolated from biological samples, as previously 
reported [18-21].  
Patients with microbiological diagnosis 
underwent tuberculosis treatment, according to 
guidelines 22. 
We identified the following groups of patients: 
1. Healthy control group (HCG): 47 HIV 
negative individuals who tested TST and 
QFT-IT-negative.   
2. Latent HIV negative infected TB group (LIG): 
43 HIV negative patients who reported 
household or equivalent close contact with 
smear-positive pulmonary TB patients in the 
previous 3 months, QFT-IT-positive, with 
negative chest x-ray results for active 
pulmonary lesions and no prior preventive 
therapy administered.   
3. Active HIV negative tuberculosis (TAG): 61 
patients with a microbiological diagnosis 
positive for Mycobacterium tuberculosis 
complex (53 with pulmonary tuberculosis and 
7 with extrapulmonary tuberculosis). 
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4. Treated tuberculosis HIV negative (TTG):  44 
cured TB patients who showed a previous 
microbiological diagnosis.    
5. HIV drug-naive patients (HIVnG): 44 patients 
(mean of CD4 + = 300,59 mm
3
), tested TST 
and QFT-IT-negative with negative chest x-
ray.  
6. HIV-tuberculosis co-infection (HIVTB-G): 22 
patients with TB diagnosis after two months 
of specific anti TB therapy (mean of CD4 = 70 
± 43,5 mm
3
).   
Patient medical records were collected and 
entered into a hospital medical record database. 
Informed consent, including consent to the 
publication of patient details, was signed by all 
individuals before they accessed the day health 
care services, in accordance with the Declaration 
of Helsinki.  
Statistical analysis  
Statistical analysis was performed by Matlab 
statistical toolbox version 2008 (MathWorks, 
Natick, MA, USA) for Windows at 32 bit.  
Data are presented as number and percentage 
for categorical variables and continuous data were 
expressed as mean ± standard deviation (SD), 
unless otherwise specified.  
The multiple comparison chi-square test was 
used to define significant differences among 
percentages: if chi-square test was positive (p-
value less than 0.05) then residual analysis with 
the Z-test to locate the highest or lowest 
significant presence was performed. 
Multi-comparison tests on continuous data were 
performed with one-way ANOVA test to evaluate 
significant differences among means. If the 
ANOVA test was positive, Scheffé's method was 
performed for pairwise comparison. Finally only a 
p-value < 0.05 was considered as significant.  
Results 
In Table 1, we report the characteristics and 
multivariate analysis of the enrolled population by 
patient group: gender, age, country of origin 
(Italian/Migrant), lymphocyte and monocyte 
absolute blood count and monocyte to lymphocyte 
blood ratio.  
We found a significant difference among 
groups for gender (M) (p-value < 0.0001): in 
particular, the HCG group had fewer males than 
any other (40.43%, p-value < 0.05).  
As for age, no significant difference was found 
among groups (p-value = 0.207). 
Regarding country of origin, there were 
significant differences between the groups (p-
value <0.0001): in particular, there were more 
Italian patients in the HCG group (100%, p-value 
<0.05) and fewer in the TAG (22.95%, p- value 
<0.05) and TTG groups (22.73%, p-value <0.05). 
As far as lymphocytes are concerned, there was 
a significant difference among groups (p-
value<0.001): in particular, mean value of 
lymphocytes was significantly greater in the LIG 
group than in TAG (2.22 >1.70) (1x10
3/μl ) and 
HIVnG (2.22 >1.45) (1x10
3/μl ).   
As for monocytes, there was a significant 
difference between the groups (p-value <0.001): 
in particular, the mean value of monocytes was 
significantly higher in the TAG group than in the 
HCG group (0.70 > 0.44) (1x10
3/μl), HIVnG 
(0.70>0.40) (1x10
3/μl) and HIVTB-G (0.70>0.45) 
(1x10
3/μl ). 
Finally, monocyte to lymphocyte blood RATIO 
(M/L) showed a significant difference between 
groups (p-value<0.001): in particular, the mean 
score of M/L ratio was higher in TAG than in the 
HCG (0.49>0.27), LIG (0.49>0.29), TTG 
(0.49>0.32) and HIVTB-G groups (0.49> 0.27). 
In Figures 1 and 2 we show the mean value of 
lymphocytes, monocytes and  
monocytes/lymphocytes for each group.    
Discussion 
Tuberculosis is a leading cause of death 
worldwide despite the availability of effective 
chemotherapy for over 60 years. Although 
Mycobacterium bovis bacillus Calmette-Guérin 
(BCG) vaccination protects against tuberculosis 
complications, such as tuberculosis of the central 
nervous system 23,24, its efficacy is suboptimal 
and under debate in cancer patients and in
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pregnant women 25,47. Particularly, recent 
studies show a connection between preexisting 
tuberculosis and lung cancer [27,28]. In addition,  
a correlation between breast carcinoma and 
previous repeated fluoroscopies in the treatment 
of patients with tuberculosis has been considered 
[32]. Therefore in these cases more efficient new 
treatments and diagnostic procedures should be 
considered, especially for young people or 
patients with lung cancer [29-31,33,34]. 
In this study, we found that lymphocyte 
absolute count was lower in patients with active 
tuberculosis than in other uninfected HIV patients, 
and monocyte absolute count was higher in 
patients with active tuberculosis than in other 
uninfected HIV patients.  
Regarding the statistical analysis, uninfected 
active tuberculosis patients had a significantly 
lower lymphocyte absolute count compared to 
latent infected patients; regarding monocytes, 
uninfected active tuberculosis patients had a 
significantly higher absolute count than the 
healthy subjects. These findings are in accordance 
with data we published previously 13,16. 
HIV+ patients are at increased risk of 
contracting tuberculosis disease despite ARTs and 
number of CD4+ cells [48]. Disseminated 
infection by rapidly growing mycobacteria like M. 
abscessus subsp. bolletii in patients affected by 
idiopathic CD4+ T lymphocytopenia have been 
described [49]. HIV infection is characterized by a 
reduction in total white cell count (WCC), 
neutropenia and a particular reduction in CD4
+
 T 
cells but an increase in CD8
+
 T cells.  In our study 
we found the lowest absolute lymphocyte cell 
count in ART naïve patients. We presume that this 
data is related to the underlying HIV infection.      
Regarding monocyte absolute cell count, we did 
not find any significant difference between HIV 
negative and HIV positive patients, except for 
subjects with active tuberculosis.  
Naranbhai et al. showed that in the HIV 
population the ratio of monocytes and 
lymphocytes (ML ratio) in peripheral blood is 
associated with tuberculosis. Our median 
monocyte count was 0.4, like the 50
th
 percentile 
reported by Naranbhai 16 in HIV patients who 
developed tuberculosis during follow-up. Similar 
data regarding absolute monocyte count were 
reported by Jun Wang for the Brazilian 
tuberculosis population 26. 
In conclusion, our preliminary results confirm 
the evidence demonstrated in the in vivo and vitro 
study on immunocompetent patients with 
tuberculosis 13-16,26.  
On the other hand, our study raises doubts 
about the role of M/L ratio in subjects in the HIV 
population, in naïve patients especially. To better 
outline its role as a tuberculosis biomarker for this 
group of patients, a larger number of enrolled 
subjects is needed.  
The authors encourage future research to 
evaluate the "gray phase" of inflammatory 
response against Mycobacterium tuberculosis. In 
fact, the latent and reactivation phase remains a 
difficult step in patient management, especially 
HIV positive and cancer patients.  
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Table 1. Characteristics for every group with multivariate analysis  
Variable HCG LIG TAG TTG HIVnG HIVTB-G 
Multivariate 
analysis:  p-value 
Patients 47 43 61 44 44 22  
Gender 
(M) 40.43% 76.74% 81.97% 81.82% 84.09% 77.27% 
<0.0001 (C) * 
HCG *** (Z) 
Age 42.98±13.53 44.23±17.25 37.18±18.60 38.27±18.32 40.52±11.33 42.27±9.62 0.207 (A) 
NIP 100.00% 55.81% 22.95% 22.73% 63.64% 36.36% 
<0.0001 (C) * 
HCG ** (Z) 
 TAG *** (Z) 
 TTG *** (Z) 
LC  1.75±0.45 2.22±0.25 1.67±0.64 1.90±0.65 1.46±0.89 2.01±1.15 
< 0.001 (A) * 
LIG > TAG * (Sc) 
LIG > HIVnG * 
(Sc) 
MC  0.44±0.21 0.54±0.25 0.70±0.37 0.54±0.25 0.40±0.31 0.45±0.22 
< 0.001 (A) * 
TAG >HCG * 
(Sc) 
GTA >HIVnG * 
(Sc) 
TAG >HIVTB-G 
* (Sc) 
M/L 0.27±0.16 0.29±0.22 0.49±0.40 0.32±0.16 0.33±0.20 0.27±0.19 
< 0.001 (A) * 
TAG > HCG * 
(Sc)       TAG > 
LIG* (Sc)          
TAG > TTG * 
(Sc)        TAG > 
HIVTB-G* (Sc) 
HCG = healthy control group; LIG = Latent HIV negative Infected TB group; TAG = HIV negative active tuberculosis group; TTG = 
treated HIV negative group; HIVnG = HIV Naïve group; HIVTB-G = Co-infected HIV-tuberculosis group; NIP = Italian nationality 
patients; LC = lymphocytes; MC = monocytes; A = one way ANOVA test; C = multi-comparison chi square test; Z = Z-test; * = significant 
test; * * = significant most frequent; *** = significant less frequent; Sc = Scheffé's test (it was performed with significant level less than 
0.05); MC/LC = monocyte/lymphocyte ratio; lymphocyte and monocyte values were expressed in 1x10
3
/μl 
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Figure 1. The mean value of lymphocyte absolute blood cell count (LC) and monocyte absolute blood cell 
count (MC) for every group 
0
500
1000
1500
2000
2500
LC MC
GROUP
HCG
HINnG
HIVTB-G
LIG
TAG
TTG
PhOL     Guadagnino, et al.     33 (pag 22-33) 
 
 
http://pharmacologyonline.silae.it 
ISSN: 1824-8620 
  
 
Figure 2. Mean score of monocytes / lymphocytes for every group 
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